Skip to content
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Clinical Topics
View All
Addiction
Anxiety
Bipolar Disorder
Depression
Difficult to Treat Depression
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Schizophrenia
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
Auvelity: Information from Industry
Banner Alzheimer’s Institute
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
Rounds in the General Hospital
Ronald N. Marcus, MD
JCP
Original Research
Aripiprazole Effects in Patients With Acute Schizophrenia Experiencing Higher or Lower Agitation: A Post Hoc Analysis of 4 Randomized, Placebo-Controlled Clinical Trials
May 15, 2007
Stephen R. Marder
,
Britt West
,
Gina S. Lau
, et al
JCP
Original Research
Aripiprazole for Treatment-Resistant Schizophrenia: Results of a Multicenter, Randomized, Double-Blind, Comparison Study Versus Perphenazine
February 15, 2007
John M. Kane
,
Herbert Y. Meltzer
,
William H. Carson, Jr.
, et al
JCP
Original Research
Efficacy and Safety of Intramuscular Aripiprazole in Patients With Acute Agitation: A Randomized, Double-Blind, Placebo-Controlled Trial
January 15, 2007
Tram K. Tran-Johnson
,
David A. Sack
,
Ronald N. Marcus
, et al
JCP
Original Research
A Randomized, Double-Blind, Placebo-Controlled 26-Week Trial of Aripiprazole in Recently Manic Patients With Bipolar I Disorder.
April 15, 2006
Joseph R. Calabrese
,
Robert D. McQuade
,
William H. Carson
, et al
«
1
2
